NCDs, LCDs, Discharge Planning, and Home Care – All in One Article

ICD10monitor November 1, 2023
Ronald Hirsch, MD, FACP, CHCQM, CHRI

My topic list has been overflowing with information lately, so it’s time for another rapid-fire article.

First up, a few weeks ago the Centers for Medicare & Medicaid Services (CMS) announced that they have withdrawn the national coverage determination (NCD) for amyloid PET scans used to diagnose and monitor the response to treatment of Alzheimer’s disease. The NCD previously allowed one amyloid PET scan for patients who were participating in clinical trials. However, that became a problem when CMS approved payment for Leqembi outside of clinical trials. Patients needed a PET scan to see if the drug was right for them, but it was unclear if Medicare would pay for it.

Now, having the NCD completely withdrawn is both good...

Today's Sponsors

Today's Sponsor